CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-17 | Sandrock Alfred President and CEO | Grant or award | +120,000 | 222,055 | ||
| 2023-02-17 | Sandrock Alfred President and CEO | Grant or award · Stock Option (Right to Buy) | +240,000 | 240,000 | ||
| 2023-02-13 | Carter Todd Alfred Chief Scientific Officer | Sale | −797 | $7.67 | $6K | 34,291 |
| 2023-02-13 | Hesslein Robert W. Senior VP & General Counsel | Sale | −2,868 | $7.67 | $22K | 109,907 |
| 2023-02-02 | Third Rock Ventures III, L.P. 10% owner | Other disposition | −1,500,000 | 3,185,291 | ||
| 2023-02-01 | Third Rock Ventures III, L.P. 10% owner | Sale | −128,642 | $9.32 | $1.2M | 4,685,291 |
| 2023-01-31 | Third Rock Ventures III, L.P. 10% owner | Sale | −185,000 | $9.25 | $1.7M | 4,813,933 |
| 2023-01-30 | Third Rock Ventures III, L.P. 10% owner | Sale | −75,000 | $9.03 | $677K | 4,998,933 |
| 2023-01-27 | Third Rock Ventures III, L.P. 10% owner | Sale | −50,000 | $9.02 | $451K | 5,073,933 |
| 2023-01-25 | Third Rock Ventures III, L.P. 10% owner | Sale | −50,000 | $9.22 | $461K | 5,123,933 |
| 2023-01-24 | Third Rock Ventures III, L.P. 10% owner | Sale | −100,000 | $9.27 | $927K | 5,173,933 |
| 2023-01-23 | Third Rock Ventures III, L.P. 10% owner | Sale | −55,000 | $9.06 | $498K | 5,273,933 |
| 2023-01-20 | Third Rock Ventures III, L.P. 10% owner | Sale | −100,000 | $9.15 | $915K | 5,328,933 |
| 2023-01-17 | Hesslein Robert W. Senior VP & General Counsel | Sale | −1,396 | $9.57 | $13K | 113,567 |
| 2023-01-17 | Hesslein Robert W. Senior VP & General Counsel | Sale | −792 | $10.34 | $8K | 112,775 |
| 2023-01-17 | Carter Todd Alfred Chief Scientific Officer | Sale | −706 | $9.57 | $7K | 35,488 |
| 2023-01-17 | Carter Todd Alfred Chief Scientific Officer | Sale | −400 | $10.34 | $4K | 35,088 |
| 2023-01-17 | Swartz Robin Chief Operating Officer | Sale | −1,396 | $9.57 | $13K | 52,695 |
| 2023-01-17 | Swartz Robin Chief Operating Officer | Sale | −792 | $10.34 | $8K | 51,903 |
| 2023-01-11 | EcoR1 Capital, LLC 10% owner | Sale | −110,000 | $8.50 | $935K | 3,851,507 |
Page 8 of 19 · 368 trades